Your browser doesn't support javascript.
loading
In vitro and in vivo growth-inhibitory effects of cladribine on neoplastic mast cells exhibiting the imatinib-resistant KIT mutation D816V.
Böhm, Alexandra; Sonneck, Karoline; Gleixner, Karoline V; Schuch, Karina; Pickl, Winfried F; Blatt, Katharina; Peter, Barbara; Herrmann, Harald; Schernthaner, Gerit-Holger; Pehamberger, Hubert; Rabitsch, Werner; Sperr, Wolfgang R; Valent, Peter.
Affiliation
  • Böhm A; Department of Medicine I, Division of Hematology and Hemostaseology, Medical University of Vienna, Vienna, Austria.
Exp Hematol ; 38(9): 744-55, 2010 Sep.
Article in En | MEDLINE | ID: mdl-20553795
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Cladribine / Proto-Oncogene Proteins c-kit / Drug Resistance, Neoplasm / Mutation, Missense / Mastocytosis, Systemic / Mast Cells / Antineoplastic Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Exp Hematol Year: 2010 Document type: Article Affiliation country: Austria Country of publication: Netherlands
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Pyrimidines / Cladribine / Proto-Oncogene Proteins c-kit / Drug Resistance, Neoplasm / Mutation, Missense / Mastocytosis, Systemic / Mast Cells / Antineoplastic Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Exp Hematol Year: 2010 Document type: Article Affiliation country: Austria Country of publication: Netherlands